Kleinmachnow, Germany

Axel Bouchon

This inventor holds 6 USPTO granted patents and 11 published patent applications and 3 EPO patents. Top assignees: Modernatx, Inc., Matter Neuroscience Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Axel Bouchon. Retrieved from https://idiyas.com/inventor/axel-bouchon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 225(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Biography of Axel Bouchon

Introduction

Axel Bouchon is a prominent inventor based in Kleinmacknow, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid vaccines.

Latest Patents

Bouchon holds a total of 5 patents, with his latest inventions focusing on nucleic acid vaccines. These inventions relate to compositions and methods for the preparation, manufacture, and therapeutic use of ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more antigens.

Career Highlights

Axel Bouchon is currently associated with Modernatx, Inc., where he continues to innovate in the field of vaccine development. His work has been instrumental in advancing the understanding and application of RNA technology in therapeutics.

Collaborations

Throughout his career, Bouchon has collaborated with notable scientists such as Giuseppe Ciaramella and Eric Yi-Chun Huang, contributing to the advancement of research in nucleic acid vaccines.

Conclusion

Axel Bouchon's work exemplifies the impact of innovative thinking in biotechnology. His contributions to nucleic acid vaccines are paving the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…